ClinicalTrials.gg
DrugRead study by study

Anastrozole clinical trials

Also written Arimidex, ZD1033 and ICI-D1033.

studies test it
170
open now
22
in phase 3
45
first study started
1996
ClinicalTrials.gov finds 495 studies for Anastrozole. How that becomes 170 hereChecked on ClinicalTrials.gov

Every study that search finds has been read, to see whether and how it gives Anastrozole. Its counts are asked again every night. How drug pages count

  1. 495Found by its intervention search · See all 495 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 358 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. −14
    Mention it without giving it — earlier treatment, a protocol code, a title naming another drug
  3. 481Give Anastrozole to participants
  4. −63Observe patients on it, or give it outside a trial
  5. −42Compare another treatment with it
  6. −206Give it beside what is tested
  7. 170Test it: the count on this site

Get an email when these change. Save the Anastrozole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Dec 1995 · ARIMIDEX · NDA 020541 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Anastrozole
93
Anastrazole
10
Anastrozole (Arimidex)
5
Anastrozole 1mg
4
ANAS
3

Brand

Arimidex
66
Arimidex 1 mg
1

Development codes

ZD1033
13
ICI-D1033
7
NSC-719344
1

Studies by the year they started

170 studies that test it; most in 2005 (12)

Studies that test Anastrozole, by start year
YearStudies
19964
19971
19984
19991
20002
20014
20022
20036
20049
200512
200610
200710
200811
20094
20108
20116
20124
20134
20148
20159
20166
20179
20182
20194
20208
20213
20223
20234
20244
20255
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
19
Phase 2
80
Phase 3
45
Phase 4
14
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 38 · Other 132

AstraZeneca (23) · Fudan University (7) · Mayo Clinic (4) · Massachusetts General Hospital (4) · UNICANCER (3) · Ottawa Hospital Research Institute (3) · Peking Union Medical College Hospital (3) · Alliance for Clinical Trials in Oncology (2)

Often tested with

Tested in the same studies.

Exemestane (39) · Tamoxifen (25) · Letrozole (18) · Fulvestrant (13) · Testosterone (11) · Goserelin (10) · Aromatase inhibitors (8) · Palbociclib (6)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 15 phase 3 studies under way

Anastrozole is the comparator. A study of two new drugs counts under both.

  • 4AZD9833 · AstraZeneca · next primary completion Apr 2027
  • 2Elacestrant · Stemline Therapeutics, Inc., European Organisation for Research and Treatment of Cancer - EORTC · next primary completion Aug 2029
  • 2HRS-8080 · Shandong Suncadia Medicine Co., Ltd. · next primary completion Aug 2027
  • 1Letrozole · Stemline Therapeutics, Inc. · next primary completion Aug 2029
  • 1Tamoxifen · Stemline Therapeutics, Inc. · next primary completion Aug 2029
  • 1Giredestrant · Hoffmann-La Roche
  • 1Palazestrant · Olema Pharmaceuticals, Inc.
  • 1Imlunestrant · Eli Lilly and Company · next primary completion Oct 2027
New treatments tested with it · 8 most studied

New when their studies opened, with Anastrozole beside them; studies of each.

Reaching primary completion within a year · 6, 2 in phase 3

Studies that test Anastrozole, phase 3 first.

Studies

Open first, then newest update. How each study uses Anastrozole has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 170

See all 170 studies that test Anastrozole →

Tested on its own · 40 — no other medicine in its arm

Showing 20 of 40. See all 40 →

Tested with established drugs · 8 — they are given beside it
Tested in a combination · 122 — another drug in the study is under test too

Showing 20 of 122. See all 122 →

Beside an established treatment under test · 21 — an approved drug, surgery or radiation is what the study tests

Tested with Anastrozole: Fulvestrant 7 · Gefitinib 3 · Trastuzumab 2 · vistusertib 1 · saracatinib 1 · Nivolumab 1 · lonafarnib 1 · pertuzumab 1

Showing 20 of 21. See all 21 →

Beside a new treatment under test · 25 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with Anastrozole: abemaciclib 2 · Bireociclib 2 · palbociclib 1 · AZD9833 1 · capivasertib 1 · onapristone 1 · xentuzumab 1 · enzalutamide 1

Showing 20 of 25. See all 25 →

Beside supportive care · 25 — a supportive treatment or test is studied

Showing 20 of 25. See all 25 →

One option of several · 135 — a test or a strategy chooses among drugs

Showing 20 of 135. See all 135 →

As the comparator · 42 — what is tested is compared with Anastrozole

Showing 20 of 42. See all 42 →

Observed · 63 — patients on it are followed, or it is given outside a trial

Showing 20 of 63. See all 63 →

Codes

What other systems call Anastrozole · ClinicalTrials.gg INT006710

  • MeSH (NLM) D000077384AnastrozoleConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 2Z07MYW1AZANASTROZOLEConfirmed FDA, NLM, Wikidata
  • RxNorm 84857Confirmed FDA, Wikidata
  • Wikidata Q419143anastrozoleConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1607AnastrozoleOne source FDA
  • DrugBank DB01217One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion